Back
Jaguar Health Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Sell
25
JAGX
Jaguar Health
Last Price:
1.20
Seasonality Move:
-34.71%
Sell
28
ALNY
Alnylam Pharmaceuticals
Last Price:
274.40
Seasonality Move:
5.61%
Sell
25
Jaguar Health (JAGX)
is a Sell
Is Jaguar Health a Buy, Sell or Hold?
- The current Jaguar Health [JAGX] share price is $1.20. The Score for JAGX is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- JAGX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
28
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
- The current Alnylam Pharmaceuticals [ALNY] share price is $274.46. The Score for ALNY is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- ALNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
JAGX Stock Price Chart
What is Jaguar Health's stock price today?
-
The Jaguar Health share price today is $1.20
The current trend is relatively stagnant and JAGX is experiencing buying pressure, which is a positive indicator for future bullish movement.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $274.46
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.
JAGX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.16 | Sell |
| Relative Strength Index (14 RSI): | 41.1 | Sell |
| Chaikin Money Flow: | 427030 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.1 - 1.2) | Buy |
| Bollinger Bands (100): | (-0.26 - 10.26) | Sell |
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.95 | Buy |
| Relative Strength Index (14 RSI): | 59.65 | Buy |
| Chaikin Money Flow: | 719597 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (256.31 - 277.53) | Buy |
| Bollinger Bands (100): | (161.67 - 267.41) | Buy |
JAGX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.12 | Buy |
| 20-day SMA: | 1.14 | Buy |
| 50-day SMA: | 1.77 | Sell |
| 200-day SMA: | 6.2 | Sell |
| 8-day EMA: | 1.13 | Buy |
| 20-day EMA: | 1.19 | Buy |
| 50-day EMA: | 2.01 | Sell |
| 200-day EMA: | 37.34 | Sell |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 261.21 | Buy |
| 20-day SMA: | 266.87 | Buy |
| 50-day SMA: | 259.05 | Buy |
| 200-day SMA: | 190.61 | Buy |
| 8-day EMA: | 265.35 | Buy |
| 20-day EMA: | 263.87 | Buy |
| 50-day EMA: | 251.75 | Buy |
| 200-day EMA: | 206.68 | Buy |
Jaguar Health Earnings Growth & JAGX Earnings Dates
- Analysts estimate an earnings increase this quarter of $71.43 per share, an increase next quarter of $1.81 per share, an increase this year of $0.43 per share, and an increase next year of $2.79 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.57 per share, an increase next quarter of $0.47 per share, an increase this year of $1.30 per share, and an increase next year of $0.57 per share.
Jaguar Health Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Alnylam Pharmaceuticals Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||